CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹42 Cr | ₹34 Cr | ₹28 Cr | ₹23 Cr | ₹21 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of CONCORD BIOTECH ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹42 Cr |
| Mar2025 | ₹34 Cr |
| Mar2024 | ₹28 Cr |
| Mar2023 | ₹23 Cr |
| Mar2022 | ₹21 Cr |
How is Deferred Tax Assets / Liabilities of CONCORD BIOTECH Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹42 Cr | 24.69 | |
| Mar2025 | ₹34 Cr | 21.23 | |
| Mar2024 | ₹28 Cr | 19.74 | |
| Mar2023 | ₹23 Cr | 11.77 | |
| Mar2022 | ₹21 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹14,175.9 Cr | -0.9% | -7.5% | -15.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,067.0 Cr | -2.3% | -5.9% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,983.0 Cr | -1.7% | -1.1% | 60.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,974.0 Cr | -2.1% | -5.1% | 32.2% | Stock Analytics | |
| CIPLA | ₹106,130.0 Cr | -2.2% | -4% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,707.0 Cr | 1.8% | 7.6% | -4.3% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -0.9% |
-7.5% |
-15.9% |
| SENSEX | -0.6% |
-4.8% |
-11.4% |
You may also like the below Video Courses